{"id":"W2736153605","doi":"10.1002/nau.23315","title":"Patient‐reported outcomes from SYNERGY, a randomized, double‐blind, multicenter study evaluating combinations of mirabegron and solifenacin compared with monotherapy and placebo in OAB patients","year":2017,"lang":"en","type":"article","venue":"Neurourology and Urodynamics","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Astellas Pharma, Netherlands; Astellas Pharma Europe","keywords":"Solifenacin; Mirabegron; Medicine; Overactive bladder; Placebo; Urology; Combination therapy; Quality of life (healthcare); Randomized controlled trial; Clinical endpoint; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002784406,0.001677043,0.003641825,0.0005347183,0.0005099861,0.0007930517,0.0006783498,0.001757354,0.004248293],"category_scores_gemma":[0.001936719,0.0007149793,0.00325568,0.0004688368,0.0008370612,0.0008776037,0.0005354137,0.001889345,0.0004826473],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005581455,"about_ca_system_score_gemma":0.001136817,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004892386,"about_ca_topic_score_gemma":0.001116821,"domain_scores_codex":[0.9985057,0.0009328897,0.0001319909,0.0001943743,0.0001297813,0.0001053034],"domain_scores_gemma":[0.9978694,0.0004380444,0.0009353003,0.0001181221,0.0001431609,0.0004960221],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9825827,0.004031563,0.001747715,0.0005538569,0.001530998,0.00001972627,0.00002457579,0.0002432634,0.002052119,0.00002865456,0.000209713,0.006975007],"study_design_scores_gemma":[0.8348245,0.1552379,0.006914551,0.00005754778,0.001704258,0.00003988401,0.00002110275,0.0003076132,0.0005365565,0.00004660979,0.000289562,0.00001992508],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9908916,0.005152007,0.0003683431,0.0002579036,0.0001418791,0.001599955,0.0008562706,0.00003446183,0.0006976139],"genre_scores_gemma":[0.9918202,0.002013324,0.001174853,0.0004298201,0.0003258274,0.002635091,0.0008669283,0.000008964984,0.0007250254],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004248293,"threshold_uncertainty_score":0.01472551,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04653445807542036,"score_gpt":0.3530978250677579,"score_spread":0.3065633669923375,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}